| Literature DB >> 32610707 |
Chia-Chun Wang1,2, Ting-Yu Shih2, Yi-Ting Hsieh2, Jie-Len Huang2, Jane Wang1,3.
Abstract
This study focuses on the development and evaluation of a novel wound dressing material. l-arginine grafted poly(glycerol sebacate) materials (PGS-g-Arg) are developed by chemical conjugation of l-arginine on poly(glycerol sebacate) chains and the mechanical property, water vapor transmission rate, antimicrobial functions and biocompatibility are investigated. At various l-arginine grafting ratio, the mechanical properties are tunable. It was found that between 7-13% l-arginine grafting ratios, the tensile strengths of PGS-g-Arg were similar to that of natural skin. These materials are shown with a low water vapor transmission rate, 6.1 to 10.3 g/m2/h, which may form a barrier and assist in the closure of wounds. Inhibition in the growth of Pseudomonas aeruginosa and Staphylococcus aureus was observed on PGS-g-Arg, and a series of experiments were conducted to confirm its biocompatibility. In summary, l -arginine grafted poly(glycerol sebacate) may offer a novel option for wound dressing.Entities:
Keywords: antimicrobial function; l-arginine; poly(glycerol sebacate); wound dressing
Year: 2020 PMID: 32610707 PMCID: PMC7408033 DOI: 10.3390/polym12071457
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1The preparation schemes of (A) poly(glycerol sebacate) (PGS) prepolymer, (B) PGS-g-Arg polymer, and (C) PGS-g-Arg crosslinked films (c(PGS-g-Arg)).
Figure 2The relative positions and structural analyses of (A) PGS prepolymer mix with l-arginine (5/1 w/w) and PGS-g-Arg prepolymers with the grafting content of (B) 7%, (C) 13%, and (D) 18% l-arginine, respectively on 1H-NMR spectra (d-solvent: CD3OD).
Molecular compositions and characteristics of prepolymers and crosslinked films.
| Polymer | L-Arginine Content | Molecular Weight | Solid Content in Ethanol (%) | Size of Crosslinked Films |
|---|---|---|---|---|
| Mw/Mn/PDI | ||||
| c (PGS-g- 7% Arg) | 7 | 3060/1809/1.7 | 30 | 105/104/0.24 |
| 50 | 108/108/0.46 | |||
| c (PGS-g- 13% Arg) | 13 | 3668/2221/1.7 | 50 | 106/105/0.47 |
| c (PGS-g- 18% Arg) | 18 | 5001/2420/2.1 | 50 | 107/107/0.50 |
Figure 3Attenuated Total Reflection-Fourier transform infrared (ATR-FTIR) spectra of (A) crosslinked PGS-g-Arg film (c(PGS-g-Arg)) and (B) crosslinked PGS film (c(PGS)).
Mechanical properties of c(PGS-g-Arg) flims (n = 5).
| Polymer | L-Arginine Content | Mechanical Properties | ||
|---|---|---|---|---|
| Young’s Modulus (MPa) | UTS | Elongation (%) | ||
| c (PGS-g- 7% Arg) | 7% | 1.79 ± 0.15 | 0.84 ± 0.08 | 84 ± 12 |
| c (PGS-g- 13% Arg) | 13% | 0.89 ± 0.06 | 0.59 ± 0.08 | 112 ± 11 |
| c (PGS-g- 18% Arg) | 18% | 0.37 ± 0.05 | 0.23 ± 0.02 | 129 ± 14 |
Figure 4Comparison of swelling ratio of c(PGS-g-Arg) films with varying grafting ratios (n = 3).
Comparison of the water vapor transmission rates (WVTRs) of c(PGS-g-Arg) with commercial products by vial method (n = 3).
| Tested Sample | Thickness (mm) | Water Vapor Transmission Rate (g/m2/h) |
|---|---|---|
| c (PGS-g- 7% Arg) | 0.46 ± 0.05 | 6.1 ± 0.3 |
| 0.24 ± 0.01 | 10.3 ± 0.5 | |
| c (PGS-g- 13% Arg) | 0.47 ± 0.04 | 7.7 ± 0.3 |
| c (PGS-g- 18% Arg) | 0.50 ± 0.06 | 8.3 ± 0.4 |
| Cica-Care ® | 1.00 | 7.2 ± 1.0 |
| SavDerm ® | 0.50 | 7.8 ± 0.7 |
| Rystora ® | 0.30 | 12.2 ± 0.3 |
| 0% occlusive control of water | 0.00 | 174.1 ± 8.2 |
Figure 5Comparison of the WVTRs of c(PGS-g- 13% Arg) with SavDerm® by Mocon method (n = 2).
Figure 6The capability of (A) anti-Pseudomonas aeruginosa and (B) anti-Staphylococcus aureus of c(PGS-g-Arg) films (n = 2).
Figure 7Optical observation of L929 cell lines via neutral red staining (scale bar 100 μm).
Evaluation of cytocompatibility of c(PGS-g-Arg) films (n = 3).
| Tested Sample | Reactivity Grades of Zone | Morphological Grades of Cytotoxicity |
|---|---|---|
| Positive control | 3, 3, 3 | 3, 3, 3 |
| Negative control | 0, 0, 0 | 0, 0, 0 |
| c (PGS-g- 7% Arg) | 1, 1, 1 | 1, 1, 1 |
| c (PGS-g- 13% Arg) | 1, 1, 1 | 1, 1, 1 |
| c (PGS-g- 18% Arg) | 1, 1, 1 | 1, 1, 1 |